Action 002826 TIBET AIM PHARM. INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Tibet AIM Pharm. Inc.

Actions

002826

CNE100002C39

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 29/04/2024 		Varia. 5j. Varia. 1 janv.
8,88 CNY +3,02 % Graphique intraday de Tibet AIM Pharm. Inc. +11,98 % -25,19 %
26/04 Tibet Aim Pharm. Inc. propose un dividende final pour 2023 CI
25/04 Tibet AIM Pharm. Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.
Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.
Tibet AIM Pharm. Inc. announces an Equity Buyback for CNY 100 million worth of its shares.
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tibet AIM Pharm. Inc. authorizes a Buyback Plan.
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Tibet AIM Pharm. Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 07 July 2023
Tibet AIM Pharm. Inc. Approves Cash Dividend for 2022
Tibet Aim Pharm. Inc. Proposes Final Cash Dividend for the Year 2022
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tibet AIM Pharm. Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Tibet Aim Pharm Chairman Resigns; Successor Named
Tibet Aim Pharm Unit to Buy 21% Stake in US Medtech Firm Pier 88 Health for $6 Million
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Tibet Aim Pharm. Inc. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares) for the Year 2021, Payable on 8 July 2022
Tibet AIM Pharm. Inc. Approves 2021 Profit Distribution Plan
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002826
  4. Actualités Tibet AIM Pharm. Inc.
  5. Autres langues